1. Home
  2. ODTX vs ASTE Comparison

ODTX vs ASTE Comparison

Compare ODTX & ASTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$26.77

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

ASTE

Astec Industries Inc.

HOLD

Current Price

$43.27

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ODTX
ASTE
Founded
N/A
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Construction/Ag Equipment/Trucks
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2025
2003

Fundamental Metrics

Financial Performance
Metric
ODTX
ASTE
Price
$26.77
$43.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$66.00
AVG Volume (30 Days)
126.1K
263.0K
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
0.85%
EPS Growth
N/A
784.21
EPS
N/A
0.51
Revenue
N/A
N/A
Revenue This Year
N/A
$14.72
Revenue Next Year
N/A
$5.44
P/E Ratio
N/A
$85.39
Revenue Growth
N/A
N/A
52 Week Low
$15.10
$40.47
52 Week High
$26.49
$65.69

Technical Indicators

Market Signals
Indicator
ODTX
ASTE
Relative Strength Index (RSI) 76.70 36.83
Support Level $19.84 $43.49
Resistance Level N/A $47.56
Average True Range (ATR) 1.82 1.88
MACD 0.63 0.11
Stochastic Oscillator 100.00 34.59

Price Performance

Historical Comparison
ODTX
ASTE

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. The company has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

Share on Social Networks: